Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PHYSICIAN PERSPECTIVE - 81st Scientific Sessions of the American Heart Association
Update on Atrial Fibrillation Outcomes: Role of Evolving Therapies in AF Management
New Orleans, Louisiana / November 9-12, 2008
Reviewed and edited by: Paul Dorian, MD Professor of Medicine, Division of Cardiology, St. Michael’s Hospital, Toronto, Ontario The morbidity and mortality associated with atrial fibrillation (AF) is both substantial and costly. As...
PHYSICIAN PERSPECTIVE - Based on presentations during the 81st Scientific Sessions of the American Heart Association
Balancing Efficacy Against Risk in ACS Patients: Reviewing Antiplatelet Therapy
New Orleans, Louisiana / November 9-12, 2008
Editorial overview: John Eikelboom, MBBS, MSc, FRACP, FRCPA, FRCPC Division of Haematology and Thromboembolism, Associate Professor of Medicine, McMaster University, Hamilton, Ontario The AHA/ACC guidelines recommend ASA be used at a...
ABSTRACTS in PERSPECTIVE based on presentations from the American Heart Association 2008 Scientific Sessions
Refining Antiplatelet Therapies: Understanding Variations in Patient Response and Bleeding Risk
New Orleans, Louisiana / November 8-12, 2008
EDITORIAL REVIEW: Jean-François Tanguay, MD, FRCPC, FACC, FAHA Interventional Cardiologist and Senior Scientist, Montreal Heart Institute, Associate Professor of Medicine, Université de Montréal, Montreal, Quebec I n multiple clinical...
MEDICAL FRONTIERS - 81st Scientific Sessions of the American Heart Association
Expanding the Role of Statins in Primary Prevention: Findings from JUPITER
New Orleans, Louisiana / November 8-12, 2008
The strategy of employing high-sensitivity C-reactive protein (hsCRP) as a tool for selecting otherwise healthy patients for lipid-lowering therapy is impressively effective. In JUPITER (Justification of the Use of Statins in Prevention; an...
MEDICAL FRONTIERS - Canadian Cardiovascular Congress
New Perspectives on Cardiovascular Event Prevention in High-risk Patients
Toronto, Ontario / October 25-29, 2008
Three recently completed trials investigating the vasculoprotective impact of the angiotensin receptor blocker (ARB) telmisartan, collectively including more than 50,000 patients, contributed a wealth of data to the knowledge base on...
Canadian Cardiovascular Congress
Lipids and Inflammation—Stabilizing the Vulnerable Plaque
Toronto, Ontario / October 25-29, 2008
Toronto - Plaque rupture plus thrombus formation may set the stage for a myocardial infarction, but what makes a plaque rupture and can it be predicted or at least prevented? Increasingly, the answer would seem to be yes. Given the anatomy...
PRIORITY PRESS - Canadian Cardiovascular Congress
Cardiovascular Risk Stratification for Primary Prevention
Toronto, Ontario / October 25-29, 2008
Chronic kidney disease (CKD) is defined as both a low glomerular filtration rate of <60 mL/min plus abnormal albuminuria. Just how CKD affects outcomes was clarified in a sub-analysis of the HOPE study in which approximately 10% of the...
PRIORITY PRESS - Canadian Cardiovascular Congress
Modern Management of ACS/STEMI: Timely Intervention Critical to Optimize Outcomes
Toronto, Ontario / October 25-29, 2008
Oral antiplatelet therapy is among the most widely used treatments in clinical medicine today, as pointed out by Dr. John Eikelboom, Associate Professor of Medicine, McMaster University, Hamilton, Ontario, and its beneficial effect on...
Canadian Cardiovascular Congress
Update on Drug-eluting Stents in Percutaneous Coronary Intervention
Toronto, Ontario / October 25-29, 2008
Toronto -According to a large Canadian observational study, late mortality and adverse clinical outcomes following percutaneous coronary intervention are independently associated with various clinical factors. However, better survival out...